Julia Jones
InvestorInvestor at ALSA Ventures
Sydney, Australia
Writes $100K – $5M checks · typically $1.5M
About
Julia has a thirty-year background in pharma and CRO with companies including Johnson & Johnson, Iqvia and Novotech, plus experience in clinical nursing and research.
Experience
- ALSA VenturesInvestment Managercurrent2018 — presentGreater Sydney Area
- Agilex Biolabs Pty LtdChief Commercial Officer2021Adelaide, South Australia, Australia
- Agilex Biolabs Pty LtdVP, Business Development2019 — 2021Adelaide
- Novotech (Australia) Pty LimitedSenior Advisor2018Greater Sydney Area
- Novotech (Australia) Pty LimitedVP, Business Development2009 — 2018Sydney, Australia
- Novotech (Australia) Pty LimitedDirector, Business Development2004 — 2008
- Quintiles, AustraliaAssociate Director, BD1998 — 2004
- Johnson & Johnson ResearchCRA1989 — 1998Sydney
Education
- Arundel
Skills & more
Business Development8Clinical Development12Clinical Trials15Clinical Research4Life Sciences2BiotechnologyRegulatory Affairs1Regulatory Submissions1EDC1CRO Management1CTMS2Clinical Trial Management System (CTMS)1
+2 more
Pharmaceutical IndustryCROFrom Julia's professional profile.
Shared employers
Also worked at Quintiles, Australia28
Alain HuriezVenture Partner at Advent Life SciencesDana Marohn SpiliotisPartner at Operator CollectiveRoel DekkersInvestment manager at NoaberMaulik MehtaManaging Partner at Excelerate Health VenturesMartin GouldstoneDigital Pharma Advisor at Excelerate Health VenturesJeanne HechtDigital Pharma Advisor at Excelerate Health Ventures
+ 22 more
Colleagues at ALSA Ventures
Alek Safarian
CEO at ALSA Ventures
Andre Badalyan
Senior Analyst at ALSA Ventures
Bruce Goldsmith
Operating Partner at ALSA Ventures
Gerard Evan
Advisor at ALSA Ventures
Graeme Martin
Venture Partner at ALSA Ventures
Jasmin Fisher
Advisor at ALSA Ventures
Jyoti Choudhary
Advisor at ALSA Ventures
Katie Sunnucks
Associate at ALSA Ventures